Abstract
Objective of the Paper: To analyze the development and course of gastric MALT-lymphoma in a patient with chronic gastritis associated with Helicobacter pylori. Key points. Regression of gastric MALT-lymphoma, diagnosed in a 68-year-old patient at stage IE2, was achieved by a combination of 6 courses of immunochemotherapy according to the R-B protocol (rituximab and bendamustine) and H. pylori eradication. Conclusion. Clinical observation demonstrates the etiological relationship between gastric MALT-lymphoma and the H. pylori infection in the upper digestive tract, as well as the positive effect of immunochemotherapy and persistent eradication therapy, which contributed to the regression of gastric MALT-lymphoma itself and affected intra-abdominal lymph nodes. Keywords: gastric MALT-lymphoma, regressive course, Helicobacter pylori, eradication therapy, immunochemotherapy.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
